New drug hopes to ease breathing and heart strain in lung disease patients
Disease control
Recruiting now
This study tests a drug called mirivadelgat in people with high blood pressure in the lungs caused by lung scarring (PH-ILD). The goal is to see if it improves blood flow in the lungs, exercise ability, and overall well-being. About 126 participants will take the drug or a placeb…
Phase: PHASE2 • Sponsor: Foresee Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC